Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.63 +0.04 (+1.54%)
At close: Sep 30, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Total Current Liabilities (2014 - 2026)

Updated

Rocket Pharmaceuticals (RCKT) reported Total Current Liabilities of $31.32 million for Q2 2026, down 27.8% from $43.4 million a year earlier but up 28.0% from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Total Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Rocket Pharmaceuticals posted Total Current Liabilities of $30.21 million, down 25.8% from FY2024.

  • Total Current Liabilities has a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $40.68 million in FY2024 (-16.1%), $48.51 million in FY2023 (+23.8%), $39.17 million in FY2022 (+76.7%) and $22.17 million in FY2021 (-32.0%).
  • Five-year quarterly Total Current Liabilities spans a low of $22.17 million in Q4 2021 and a high of $48.51 million in Q4 2023.
  • Year over year, Total Current Liabilities has now declined in each of the last four quarters, with an average decline of 10.1% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q4 2022 (growth of 76.7%); the low point was Q1 2022 (a decline of 44.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $24.47 million (Q1 2026), $30.21 million (Q4 2025) and $31.17 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 Rocket Pharmaceuticals 283.71 Mn 283.71 Mn - 31.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.32 Mn
Mar 31, 2026 24.47 Mn
Dec 31, 2025 30.21 Mn
Sep 30, 2025 31.17 Mn
Jun 30, 2025 43.40 Mn
Mar 31, 2025 35.31 Mn
Dec 31, 2024 40.68 Mn
Sep 30, 2024 39.98 Mn
Jun 30, 2024 37.59 Mn
Mar 31, 2024 32.96 Mn
Dec 31, 2023 48.51 Mn
Sep 30, 2023 33.48 Mn
Jun 30, 2023 34.35 Mn
Mar 31, 2023 31.21 Mn
Dec 31, 2022 39.17 Mn
Sep 30, 2022 30.18 Mn
Jun 30, 2022 24.29 Mn
Mar 31, 2022 22.57 Mn
Dec 31, 2021 22.17 Mn
Sep 30, 2021 24.49 Mn
API Access

Rocket Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RCKT&period=max&api_key=YOUR_API_KEY